Journal profile · Rheumatology
ARTHRITIS AND RHEUMATISM
ISSN 0004-3591 · UNITED STATES · Monthly · Founded 1958
ARTHRITIS AND RHEUMATISM: impact factor 9.9 (journal website); subscription journal; APC about USD 70; review about 93 days (submission to acceptance, publisher); community-reported acceptance: about 25%; 307 articles a year.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, ARTHRITIS AND RHEUMATISM's largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Osteoarthritis Treatment and Mechanisms, together about 44.7% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Arthritis & Rheumatology, an official journal of the American College of Rheumatology, is a peer-reviewed publication for scientists and clinicians interested in the natural history, pathophysiology, treatment, and outcome of rheumatic disease. Arthritis & Rheumatology is known internationally as a top rheumatology research journal publishes the highest quality basic and clinical research related to rheumatic disease, encompassing a wide range of areas of investigative activity. Types of articles published include: Guidelines Original articles Review articles Editorials Clinical images Educational materials Abstracting and Indexing Information Abstracts in Anthropology (Sage) Abstracts on Hygiene & Communicable Diseases (CABI) Academic Search (EBSCO Publishing) Academic Search Alumni Edition (EBSCO Publishing) Academic Search Premier (EBSCO Publishing) AgBiotech News & Information (CABI) AgBiotechNet (CABI) Agricultural & Environmental Science Database (ProQuest) Agricultural Economics Database (CABI) Animal Breeding Abstracts (CABI) Animal Production Database (CABI) Animal Science Database (CABI) Biological Abstracts (Clarivate Analytics) Biological Science Database (ProQuest) BIOSIS Previews (Clarivate Analytics) Botanical Pesticides (CABI) CAB Abstracts® (CABI) CAS: Chemical Abstracts Service (ACS) Chemical Abstracts Service/SciFinder (ACS) Current Contents: Clinical Medicine (Clarivate Analytics) Current Contents: Life Sciences (Clarivate Analytics) Embase (Elsevier) EMCare (Elsevier) Environmental Impact (CABI) Environmental Science Database (CABI) Global Health (CABI) Health & Medical Collection (ProQuest) Health Research Premium Collection (ProQuest) HEED: Health Economic Evaluations Database (Wiley-Blackwell) Helminthological Abstracts (CABI) Hospital Premium Collection (ProQuest) IDIS: Iowa Drug Information Service (University of Iowa) International Pharmaceutical Abstracts (Clarivate Analytics) Journal Citation Reports/Science Edition (Clarivate Analytics) Materials Science & Engineering Database (ProQuest) MEDLINE/PubMed (NLM) Natural Science Collection (ProQuest) Nutrition & Food Sciences Database (CABI) Nutrition Abstracts & Reviews Series A: Human & Experimental (CABI) Parasitology Database (CABI) Pig News & Information (CABI) Plant Breeding Abstracts (CABI) Plant Genetics and Breeding Database (CABI) Plant Protection Database (CABI) ProQuest Central (ProQuest) Protozoological Abstracts (CABI) PubMed Dietary Supplement Subset (NLM) Review of
From the journal's Aims & Scope
Research area (LetPub): Rheumatology
Editor-in-chief S. Louis BridgesPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 4, Japan 2, United States 1, South Korea 1, Germany 1 (13 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine22%
- Systemic Lupus Erythematosus ResearchMedicine14.5%
- Osteoarthritis Treatment and MechanismsMedicine8.2%
- Spondyloarthritis Studies and TreatmentsMedicine5.8%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.5%
- Autoimmune and Inflammatory Disorders ResearchMedicine5.4%
- Systemic Sclerosis and Related DiseasesMedicine5.2%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEWeb of ScienceScopusMEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 9.9Publisher website ·
- Impact factor (publisher) 2025
- 9.9Publisher website ·
- CiteScore (publisher)
- 19.9Publisher website ·
- CiteScore (publisher) 2025
- 19.9Publisher website ·
- h-index
- 426OpenAlex ·
- i10-index
- 12,993OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher)
- 1,999Publisher website ·
- Articles per year (publisher) 2025
- 307Publisher website ·
- Downloads per year (publisher) 2025
- 2,226,794Publisher website ·
Articles by year OpenAlex count · 20,554 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2021 | 1 | 0 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
93 dayssubmission to acceptance · community reports about 1 month
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Acceptance rate (publisher)
- 16%Publisher website ·
- Acceptance rate (publisher) 2025
- 16%Publisher website ·
- Submission to first decision
- 4 daysPublisher website ·
- Submission to first decision 2025
- 4 daysPublisher website ·
- Submission to acceptance 2025
- 93 daysPublisher website ·
- Acceptance to publication 2025
- 74 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 70 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- USD 70
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted9
- brief reportBrief Report 2500; 15; 3 Yes, structured, 250 wordsLength not stated
- clinical imageClinical Image 300; 3; 2 NoLength not stated
- editorialEditorial 1500; 15; 1 NoLength not stated
- expert perspectives on clinical challengesExpert Perspectives on Clinical Challenges 5000; 85; 6 Yes, unstructured, 250 wordsLength not stated
- full lengthFull Length 4200; 50; 6 Yes, structured, 250 wordsLength not stated
- letter to the editorLetter to the Editor 500; 10; 2 NoLength not stated
- notes from the fieldNotes from the Field 1500; 15; 1 NoLength not stated
- replyReply 500;5; 1 NoLength not stated
- reviewFor detailed instructions on formatting manuscripts by article type, review this document.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship Criteria
At the revision stage, the corresponding author must provide a listing of each co-author’s contributions, and the journal may publish this information. A downloadable form, in Microsoft Word, is provided on the manuscript submission site to assist corresponding authors in compiling the information. Arthritis & Rheumatology requires that individuals must meet the first 3 of the 4 authorship criteri…
Source ↗Publisher website ·- Conflicts of interest Disclosure of interest
The journal uses the International Committee of Medical Journal Editors (ICMJE) disclosure of interest form to collect all author disclosures prior to acceptance. For revised manuscripts, the corresponding author should: collect a completed ICMJE disclosure of interest form from each co-author, combine all individual forms into a single PDF file upload the combined file with the manuscript files u…
Source ↗Publisher website ·- Data availability Data sharing policy
Data sharing statement required Model summary
Authors are required to provide a Data Sharing Statement to be published along with accepted manuscripts. This statement should indicate whether data will or will not be shared. The manuscript submission system includes specific questions regarding data sharing, including the following options: No data were used in this article; No data other than what is included in this article or supplementary …
Source ↗Publisher website ·- License & copyright Copyright: Wiley Online Licensing Service
Upon acceptance (except letters to the editor and replies, which are exempt), the corresponding author will receive an email with a link to the Copyright: Wiley Author Licensing Service. The Author must promptly complete and electronically sign the appropriate copyright and/or license agreement. The article will not be published in an issue if this has not been done.
Source ↗Publisher website ·- Open access Open Access
Arthritis & Rheumatology offers authors an open access publication option. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver. Editorial decisions at Arthritis & Rheumatology are independent of the processing of APC payments and waivers. If the Open Access option is selected the corresponding author will have…
Source ↗Publisher website ·- Peer review Peer review assignments and procedures
Single-blind peer review Model summary
Arthritis & Rheumatology follows a single-blind peer review process. Authors may suggest potential reviewers for manuscript or individuals authors would prefer not to review. (Editors will consider these suggestions but are not bound by them.) Arthritis & Rheumatology requests that peer reviewers adhere to a set of basic principles during the peer-review process in research publication. You should…
Source ↗Publisher website ·- Preprints
Preprint server submissions accepted Model summary
Publication on a preprint server is not considered to be prior publication, and the journal accepts the submissions of manuscripts that have been previously posted on a preprint server.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Country or region
- UNITED STATES
- Frequency
- Monthly
- Founded
- 1958
- ISSN
- 0004-3591
- Society / sponsor
- American College of Rheumatology
- Latest issue on the website
- Volume 78, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about ARTHRITIS AND RHEUMATISM
What is the impact factor of ARTHRITIS AND RHEUMATISM?
The journal's website gives an impact factor of 9.9 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 426.
How long does peer review take at ARTHRITIS AND RHEUMATISM?
The publisher reports about 93 days (submission to acceptance); authors report an average review time of about 1 month; the community-reported acceptance is “about 25%”; the journal's website gives an acceptance rate of 16% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ARTHRITIS AND RHEUMATISM?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of ARTHRITIS AND RHEUMATISM based?
Of the 13 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (4), Japan (2) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index ARTHRITIS AND RHEUMATISM?
The journal's website lists SCIE, Web of Science, Scopus, MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is ARTHRITIS AND RHEUMATISM open access, and what is the APC?
ARTHRITIS AND RHEUMATISM is a subscription journal. APC about USD 70.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .